Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05754008

Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes

A Randomized Trial of Care Navigator to Support Younger Latinx Adults Newly Diagnosed With Type 2 Diabetes (AURORA)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
204 (estimated)
Sponsor
Kaiser Permanente · Academic / Other
Sex
All
Age
21 Years – 44 Years
Healthy volunteers
Accepted

Summary

The study proposes to rigorously evaluate a proactive, culturally responsive care navigator intervention targeting younger-onset Latinx individuals with a new T2D diagnosis (AURORA \[Active Outreach to Younger Latinx\]) within Kaiser Permanente Northern California (KPNC).

Detailed description

The study has three primary objectives: 1) learn what is required to create and sustain a care navigator workforce and document our experience hiring a care navigator for the study, 2) implement and evaluate the AURORA strategy within KPNC, and 3) refine and adapt the AURORA strategy for future Kaiser Permanente (KP) wide dissemination. The AURORA strategy centers on a care navigator who will proactively conduct three telemedicine visits tailored to Latinx adults with early onset type 2 diabetes (T2D, defined as age \<45 years). The AURORA strategy will conducted with the following five goals: 1) assessment of familiarity and use of T2D care within KP, 2) assessment of individual's self-management support needs, 3) motivational interviewing to support behavior change, 4) pragmatic skills training, including use of crucial technologies to support self-management, and 5) matching member's needs with existing KPNC T2D resources.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAURORA Care StrategyParticipants will be invited to partake in three telemedicine visits with the care navigator during the months following diagnosis. The visits center around proactive and tailored T2D self-management support.

Timeline

Start date
2023-03-31
Primary completion
2025-04-01
Completion
2025-12-01
First posted
2023-03-03
Last updated
2024-05-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05754008. Inclusion in this directory is not an endorsement.